Systemic Lupus Erythematous and Neuromyelitis Optica Causing Hypercapnic Respiratory Failure

Area of Science:

• Neurology
• Immunology
• Neuroimmunology

Background:

• Neuromyelitis optica (NMO) is a rare, immune-mediated neurological disorder.
• Characterized by optic neuritis, transverse myelitis, and specific MRI findings (spinal cord lesions >3 vertebral segments).
• Seropositivity for Aquaporin-4 antibodies (AQP-4 Ab) is a key diagnostic marker.

Observation:

• A case report details a 54-year-old woman with symptoms including chest pain, dysphagia, weakness, diplopia, and paresthesias.
• Brain MRI showed cervical medullary junction hyperintensity; NMO diagnosis was considered after poor response to SLE myelitis treatment.
• The patient experienced acute respiratory failure, encephalopathy, and required intubation, with limited recovery.

Findings:

• NMO diagnosis can be delayed, especially when overlapping with other autoimmune conditions like Systemic Lupus Erythematosus (SLE).
• Despite aggressive treatments (steroids, immunosuppressants, stem cell transplant), progressive and permanent neurological damage can occur.
• Clinical suspicion is vital for timely intervention in NMO cases.

Implications:

• Highlights the challenges in diagnosing and managing NMO, emphasizing the need for high clinical suspicion.
• Underscores the potential for severe, irreversible neurological deficits despite comprehensive treatment strategies.
• Suggests a need for improved diagnostic pathways and potentially novel therapeutic approaches for NMO.